Table 3. Performance of io CT/NG Assay Using Male Urine for Detection of Chlamydia and Gonorrhea Compared With the Composite Infection Status.
Symptom status | No. | Chlamydia | Gonorrhea | ||||||
---|---|---|---|---|---|---|---|---|---|
Sensitivity | Specificity | Sensitivity | Specificity | ||||||
No./total No. (%) | 95% CI | No./total No. (%) | 95% CI | No./total No. (%) | 95% CI | No./total No. (%) | 95% CI | ||
Asymptomatic | 614 | 56/60 (93.3) | 84.1-97.4 | 549/554 (99.1) | 97.9-99.6 | 11/12 (91.7) | 64.6-98.5 | 602/602 (100) | 99.4-100 |
Symptomatic | 308 | 55/60 (91.7) | 81.9-96.4 | 247/248 (99.6) | 97.8-99.9 | 61/62 (98.4) | 91.4-99.7 | 246/246 (100) | 98.5-100 |
Total | 922 | 111/120 (92.5) | 86.4-96.0 | 796/802 (99.3) | 98.4-99.7 | 72/74 (97.3) | 90.7-99.3 | 848/848 (100) | 99.5-100 |
Abbreviation: CT/NG, Chlamydia trachomatis and Neisseria gonorrhoeae.